NFKB1 and Hyperglycemia: Sodium butyrate (NaB), a short-chain fatty acid, attenuates hyperglycemia-induced injury to glomerular endothelial cells (GECs) by inhibiting the typical Caspase-1/GSMD pyrolysis pathway involving the NF-κB/IκB-α signaling pathway [97].